A new survey by security firm Imprivata has found that a majority of IT leaders in healthcare view ‘passwordless’ ...

At Davos26, amid a more politically charged healthcare landscape, Fresenius’ CEO has called for a “fundamental rethink” to ...

The UK DRI has announced an international research study to assess whether a finger-prick blood test could help diagnose ...

Guardant Health has entered a multi-year strategic partnership agreement with Merck (MSD) for the development of companion ...

Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming patent cliff and AI's growth in medtech.

Ypsomed, a medical device company with a focus on self-care solutions, has announced a continued focus on delivery systems ...

Organon’s Nexplanon implant for preventing unwanted pregnancy can now be used for up to five years after the company gained ...

A medtech VC firm said kidney care is emerging as a key focus area, citing a range of startups innovating in the space after ...

Epiminder has announced the first implantation of its Minder System in the US, a device developed for ongoing monitoring of ...

Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s ...

As the curtain falls on the 44th edition of the J.P. Morgan Healthcare Conference in San Francisco, a medtech company CEO ...

Tempus AI CEO Eric Lefkofsky presented at the JP Morgan Healthcare Conference to discuss how the company is practising ...